(HBA) Hamilton Australian Bank - Ratings and Ratios
Bank, Shares, Financial, Services, Australia
Description: HBA Hamilton Australian Bank
The Hamilton Australian Bank Equal-Weight Index ETF (HBA) is an exchange-traded fund that aims to replicate the performance of the Solactive Australian Bank Equal-Weight Index TR, which comprises an equal-weighted portfolio of Australias Big 5 banks, namely Commonwealth Bank, Westpac Banking, National Australia Bank, ANZ Banking Group, and Macquarie Group.
The fund is managed by Hamilton Capital Partners, a Canadian investment manager with expertise in dividend and income-focused strategies. By tracking the Solactive Australian Bank Equal-Weight Index TR, HBA provides investors with diversified exposure to the Australian banking sector, which is known for its stability and dividend-paying history.
From a technical analysis perspective, the current price of HBA is 28.18 CAD, indicating a bullish trend as it is above its 20-day and 50-day simple moving averages (SMA20: 27.34, SMA50: 26.33). The stock is also above its 200-day simple moving average (SMA200: 27.33), suggesting a strong uptrend. The average true range (ATR) is 0.37, representing a 1.30% daily volatility. Given the current technical setup, we can expect HBA to continue its upward trajectory, potentially reaching the 52-week high of 30.07 CAD.
Fundamentally, HBA has an assets under management (AUM) of 131.34M CAD, indicating a moderate level of investor interest. The Australian banking sector is known for its resilience and ability to generate consistent profits, driven by the countrys stable economy and robust regulatory framework. With the Big 5 banks being major players in the Australian financial system, HBA provides investors with a diversified and relatively stable source of returns.
Forecasting the future performance of HBA, we can expect the fund to continue to benefit from the stability and dividend-paying capacity of the Australian banking sector. Based on the technical data, we anticipate a potential price target of 30.50 CAD in the near term, representing a 8% upside from the current price. However, investors should be cautious of potential risks, including changes in interest rates, regulatory policies, and economic conditions in Australia.
Additional Sources for HBA ETF
HBA ETF Overview
Market Cap in USD | 96m |
Category | Financial Services Equity |
IPO / Inception | 2020-06-26 |
HBA ETF Ratings
Growth Rating | 82.4 |
Fundamental | - |
Dividend Rating | 77.1 |
Rel. Strength | -5.31 |
Analysts | - |
Fair Price Momentum | 31.24 CAD |
Fair Price DCF | - |
HBA Dividends
Dividend Yield 12m | 4.53% |
Yield on Cost 5y | 10.65% |
Annual Growth 5y | 19.94% |
Payout Consistency | 92.7% |
Payout Ratio | % |
HBA Growth Ratios
Growth Correlation 3m | 95.8% |
Growth Correlation 12m | 42.2% |
Growth Correlation 5y | 91.8% |
CAGR 5y | 19.85% |
CAGR/Max DD 5y | 0.94 |
Sharpe Ratio 12m | 1.54 |
Alpha | 7.09 |
Beta | 0.593 |
Volatility | 16.86% |
Current Volume | 1.4k |
Average Volume 20d | 1.4k |
Stop Loss | 28.2 (-3.4%) |
As of July 12, 2025, the stock is trading at CAD 29.20 with a total of 1,431 shares traded.
Over the past week, the price has changed by +0.79%, over one month by +0.34%, over three months by +17.62% and over the past year by +18.69%.
Yes. Based on ValueRay's Analyses, Hamilton Australian Bank (TO:HBA) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 82.43 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HBA is around 31.24 CAD . This means that HBA is currently overvalued and has a potential downside of 6.99%.
Hamilton Australian Bank has no consensus analysts rating.
According to our own proprietary Forecast Model, HBA Hamilton Australian Bank will be worth about 35.4 in July 2026. The stock is currently trading at 29.20. This means that the stock has a potential upside of +21.2%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 35.4 | 21.2% |